Project Grant R21TW013155
- Federal Grant Award Summary Emory University received a $730,539 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded September 15, 2025, with completion targeted for March 31, 2030. This award funds a multi-national research and training initiative addressing the emerging threat of Anopheles stephensi, an invasive urban malaria mosquito vector expanding across Africa. The program leverages complementary...
- Federal Grant Award Summary Emory University received a $500,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for research titled "Immunometabolism of Myeloid Suppressor Cell Responses to M. Tuberculosis in People With HIV." The award, dated June 8, 2026, with a completion date of May 31, 2028, supports investigator-initiated biomedical research examining the immunological...
- Federal Grant Award Summary Award Overview The John E. Fogarty International Center (FIC) under the National Institutes of Health awarded George Washington University a Project Grant of $248,981 (Award Date: March 1, 2026; Completion Date: February 28, 2031) under the International Research and Research Training program (CFDA 93.989). This collaborative initiative between George Washington University's Milken Institute School of Public Health and the University of Sciences, Techniques and...
- Federal Grant Award Summary Emory University, through its Office of Sponsored Programs Division, received a $748,287 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded April 1, 2026, with a completion date of January 31, 2031. The project will develop updated population size estimates (PSEs) and health indicators for people who inject drugs (PWID) across 11 U.S. cities in collaboration with local health...
- Federal Grant Award Summary The John E. Fogarty International Center awarded a $235,410 Project Grant (CFDA 93.989: International Research and Research Training) to David Tvildiani Medical University LLC, effective September 20, 2025, through August 31, 2030. This K43 Emerging Global Leader Award supports Dr. Ilia Nadareishvili's capacity-building initiative to implement Screening and Brief Intervention (SBI) for substance use disorders in rural Georgian primary care settings. The project...
- Federal Grant Award Summary Emory University received a $1,095,500 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2026, through April 30, 2031. The project, titled "The Metabolic Crossroads: Decoding Fentanyl's Impact on HIV/HBV Co-Infection for Targeted Interventions," will deliver comprehensive research investigating how fentanyl exposure alters HIV and Hepatitis B Virus co-infection...
- Federal Grant Award Summary The John E. Fogarty International Center awarded Partnership For Research And Action For Health a $192,292 Project Grant (CFDA 93.989: International Research and Research Training) effective April 1, 2026, through March 31, 2029, to address HIV prevention and stigma reduction among men who have sex with men (MSM) in Georgia. The award funds the development and implementation of the first online HIV testing intervention trial in Georgia, delivered through collaboration...
- Federal Project Grant Summary Emory University received a $821,087 Project Grant awarded August 8, 2025, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year research study examining the relationship between latent tuberculosis infection (LTBI) and cardiometabolic disease risk. The research will generate scientific evidence establishing whether LTBI increases the risk of diabetes...
- Federal Grant Award Summary Emory University received a $1.73 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded September 15, 2025, with completion targeted for May 31, 2030. The award funds the JCOIN Phase II Innovation Hub, which will implement and rigorously evaluate a Peer Recovery Coach (PRC) program at three high-throughput jails in the Atlanta, Georgia area. The project adapts an established...
- Federal Grant Award Summary The Fogarty International Center (FIC), under the Department of Health and Human Services National Institutes of Health, awarded Makerere University College of Health Sciences a Project Grant totaling $303,316 on September 15, 2025, through the International Research and Research Training program (CFDA 93.989). The H-DATA (Harnessing Health Data Science Capacity to Strengthen Evidence-Based Interventions, Policy and Response to the HIV/AIDS Epidemic in Uganda)...
Emory University received a $201,355 Project Grant from the Fogarty International Center under the International Research and Research Training program (CFDA 93.989) for the period June 1, 2026, through May 31, 2028. The award supports research capacity building to strengthen HIV-associated non-communicable disease (NCD) research infrastructure in Mozambican prisons. The project will integrate screening for five prioritized NCDs—smoking, substance use disorders, depression, hypertension, and malnutrition—into existing mass tuberculosis screening programs at Mozambican correctional facilities. Key deliverables include transition from a tablet-based data management system to the Virtu Cares Electronic Health Record (EHR) platform and establishment of collaborative research infrastructure involving the Serviço Nacional Penitenciário (SERNAP), Instituto Nacional de Saúde (INS), and international consultants specializing in cardiovascular disease and health economics. The project builds upon established partnerships between Emory, SERNAP, and the non-governmental organization Health Through Walls, leveraging prior TB and HIV screening studies to develop evidence-based interventions applicable to resource-constrained prison settings in low- and middle-income countries. By conducting research in Mozambique's high HIV prevalence prison environment (approximately 24% prevalence compared to the 12% nationwide rate), findings can be rapidly translated to inform carceral healthcare systems globally that face similar resource constraints and disease burden.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $201.4k | 6/8/26 |